Delivery Order SPE2DB24D2010-SPE2DB25FABFP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,216.96 to supply Valtoco 10 mg nasal sprays, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,743.34 for Valtoco 10 mg nasal sprays, a medication used in emergency seizure management. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The delivery order was...
- The Defense Logistics Agency awarded a delivery order valued at $2,259.24 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 23, 2025. This non-set-aside contract utilizes firm fixed price pricing and represents a competitive award under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The place of performance is located at the company's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of September 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,259.24 firm fixed-price delivery order for Valtoco 10 mg nasal sprays on September 28, 2025, with completion scheduled for September 29, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $17,565.20 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays. This is a firm fixed price, competitively awarded contract with no set-aside designation, to be completed by September 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The delivery order is issued under...
- The Defense Logistics Agency awarded a $1,182.22 firm fixed price delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal spray on July 16, 2025, with completion scheduled for July 17, 2025. This competitively awarded, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The order will be fulfilled from the vendor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,309.22 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of July 28, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded on July 26, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,372.92 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 1, 2025. This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $5,067.89 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FABFPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,609.68 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal spray, with an ultimate completion date of September 17, 2025. This non-set-aside, firm fixed-price contract represents a competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical commodities to support military and federal healthcare systems worldwide. This delivery order for Valtoco, a nasal spray medication used in emergency seizure management, exemplifies the company's role in fulfilling specialized pharmaceutical procurement needs for the Defense Health Agency and other government healthcare systems. The competitively awarded contract demonstrates AmerisourceBergen's capability to meet federal medical supply requirements and aligns with the DLA's broader strategy of maintaining robust pharmaceutical supply chains through prime vendor relationships.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 9/16/25 |